Back

Obstruction-driven HFpEF in hypertrophic cardiomyopathy: a multimodal, guideline-based approach

10 May 2026 (10:41 - 10:52)
Organised by: Logo
Congress Presentation Part of: Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Florin Giru

Institute of Cardiovascular and Heart Diseases of Timisoara, Timisoara (Romania)

3 More presentations in this session

Presentation thumbnail
Progressive fibrosis burden and primary prevention ICD decision in hypertrophic cardiomyopathy: a genetics- and imaging-based case
Doctor O. Gok (Istanbul, TR)
Slides Video
Presentation thumbnail
Unmasking hypertrophic cardiomyopathy in women: the challenge of early detection
Doctor M. Barki (Milan, IT)
Slides
Presentation thumbnail
The thinner the better? A journey through the clinical evolution of hypertrophic cardiomyopathy
Doctor A. Parodi (Padova, IT)
Slides

Access the full session

Session thumbnail
Hypertrophic cardiomyopathy across time: early clues, evolving phenotypes, and risk
Video

The Event

Event poster

Heart Failure 2026

10 May 2026 10:41 CET
You may be interested in
thumbnail
Congress Presentation
Effects of Mavacamten use in a patient with hypertrophic obstructive cardiomyopathy and extremely high resting left ventricular outflow tract gradient
thumbnail
Congress Presentation
Mavacamten therapy in hypertrophic obstructive cardiomyopathy revealing severe aortic stenosis: a case highlighting diagnostic complexity
thumbnail
Congress Session
Myosin inhibition in hypertrophic cardiomyopathy: beyond the classic left ventricular outflow tract story

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources